Skip to main content
Disc Medicine, Inc. logo

Disc Medicine, Inc. — Investor Relations & Filings

Ticker · IRON ISIN · US36870G1058 US Manufacturing
Open in API
Filings indexed 690 across all filing types
Latest filing 2022-08-10 Merger & Acquisition
Country US United States of America
Listing US IRON

About Disc Medicine, Inc.

https://www.discmedicine.com/

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients with serious hematologic diseases. The company's research focuses on fundamental pathways of red blood cell biology to address a range of disorders. Its pipeline includes bitopertin, an investigational therapy for erythropoietic protoporphyria (EPP) for which a New Drug Application has been submitted for accelerated approval. Other clinical-stage programs are evaluating treatments for myelofibrosis-associated anemia and other conditions involving ineffective erythropoiesis.

Recent filings

Filing Released Lang Actions
8-K
Merger & Acquisition Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated August 9, 2022, by Gemini Therapeutics, Inc. It announces the entry into a material definitive agreement, specifically a merger agreement with Disc Medicine, Inc. The text details the terms of the merger, including the exchange ratio, financing transaction, contingent value rights agreement, support and lock-up agreements, and conditions for closing. It also references an investor presentation related to the merger. The document is not a full annual or quarterly report, audit report, earnings release, or other financial statement. It is a current report disclosing a significant corporate event, specifically a merger agreement and related transactions. This fits the category of Merger & Acquisition (MA) filings, which include merger communications and related agreements filed on Form 8-K. The presence of detailed merger terms and related agreements confirms this classification with high confidence.
2022-08-10 English
425 Filing
M&A Activity Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Gemini Therapeutics, Inc. It details the entry into a material definitive agreement, specifically a merger agreement with Disc Medicine, Inc. The text includes detailed descriptions of the merger terms, financing transaction, contingent value rights agreement, support and lock-up agreements, and conditions for consummation of the merger. It also references an investor presentation related to the merger. The document is not a full annual or quarterly report, nor is it an earnings release or audit report. It is a regulatory filing reporting a significant corporate event (merger agreement) and related transactions. The presence of detailed merger agreement terms and related financing indicates this is an M&A Activity filing rather than a simple announcement or proxy solicitation. Therefore, the appropriate classification is M&A Activity (Code: TAR). The document length and content support a high confidence in this classification.
2022-08-10 English
425 Filing
Call Transcript Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Gemini Therapeutics, Inc. It announces a merger agreement with Disc Medicine, Inc. The text includes details about the merger agreement, a webcast presentation transcript, press releases, social media posts, and forward-looking statements. The document also references a transcript of a webcast presentation as an exhibit, which is included in the text. The presence of a detailed transcript of the webcast presentation (Exhibit 99.1) indicates this is a Call Transcript. The document is not an earnings release, annual report, or proxy statement, but a current report disclosing a significant corporate event and including a conference call transcript. Therefore, the best classification is Call Transcript (CT).
2022-08-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-03 English
10-Q
Interim / Quarterly Report Q1 2022
2022-05-06 English
NONE
Major Shareholding Notification
2022-04-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.